Alexandra Lubin - Targeted therapeutics for AML: Automated High-Throughput Drug Screening in Zebrafish

Alexandra Lubin - Targeted therapeutics for AML: Automated High-Throughput Drug Screening in Zebrafish
Alexandra Lubin, Dept of Haematology, UCL Cancer Institute

Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Early Careers Network Session
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.

This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
Teresa Baker
635
6/6/2019
00:04:42
Alexandra Lubin, Haematology, UCL Cancer Institute, UCL Cancer Domain, Early Careers Network, Acute Myeloid Leukaemia, AML, cancer, stem cells
Download